NASDAQ: INGN
Inogen Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their INGN stock forecasts and price targets.

Forecast return on equity

Is INGN forecast to generate an efficient return?

Company
-8.78%
Industry
20.86%
Market
361.41%
INGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INGN forecast to generate an efficient return on assets?

Company
-5.64%
Industry
11.62%
INGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INGN earnings per share forecast

What is INGN's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.70
Avg 2 year Forecast
-$0.64

INGN revenue forecast

What is INGN's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$393.0M+13.24%
Avg 2 year Forecast
$408.1M+17.6%
INGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INGN revenue growth forecast

How is INGN forecast to perform vs Medical Devices companies and vs the US market?

Company
13.24%
Industry
12.11%
Market
1,551.19%
INGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
INGN$5.66N/AN/A
ANIK$10.46$16.00+52.96%Buy
QIPT$3.56$3.65+2.53%Hold
APYX$3.88$7.00+80.41%Strong Buy
NNOX$2.44$5.00+104.92%Strong Buy

Inogen Stock Forecast FAQ

What is INGN's earnings growth forecast for 2026-2027?

(NASDAQ: INGN) Inogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 40.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,359.04%.

Inogen's earnings in 2026 is -$25,377,000.On average, 4 Wall Street analysts forecast INGN's earnings for 2026 to be -$18,968,644, with the lowest INGN earnings forecast at -$22,880,741, and the highest INGN earnings forecast at -$14,538,012.

In 2027, INGN is forecast to generate -$17,307,157 in earnings, with the lowest earnings forecast at -$16,628,445 and the highest earnings forecast at -$17,817,549.

If you're new to stock investing, here's how to buy Inogen stock.

What is INGN's revenue growth forecast for 2026-2027?

(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 13.24% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,551.19%.

Inogen's revenue in 2026 is $347,028,000.On average, 4 Wall Street analysts forecast INGN's revenue for 2026 to be $10,668,267,487, with the lowest INGN revenue forecast at $10,080,774,336, and the highest INGN revenue forecast at $11,162,912,829.

In 2027, INGN is forecast to generate $11,079,295,504 in revenue, with the lowest revenue forecast at $10,644,919,792 and the highest revenue forecast at $11,405,348,773.

What is INGN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: INGN) forecast ROA is -5.64%, which is lower than the forecast US Medical Devices industry average of 11.62%.

What is INGN's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: INGN) Inogen's current Earnings Per Share (EPS) is -$1.01. On average, analysts forecast that INGN's EPS will be -$0.70 for 2026, with the lowest EPS forecast at -$0.84, and the highest EPS forecast at -$0.54. In 2027, INGN's EPS is forecast to hit -$0.64 (min: -$0.61, max: -$0.66).

What is INGN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: INGN) forecast ROE is -8.78%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.